Fenestration Improves Clinical Outcome of the Fontan Procedure

  • Matthew S. Lemler
    From the Department of Pediatrics (M.S.L., W.A.S., D.S., C.R.) and Department of Thoracic Surgery, University of Texas Southwestern Medical School (S.R.L), Dallas, Tex.
  • William A. Scott
    From the Department of Pediatrics (M.S.L., W.A.S., D.S., C.R.) and Department of Thoracic Surgery, University of Texas Southwestern Medical School (S.R.L), Dallas, Tex.
  • Steven R. Leonard
    From the Department of Pediatrics (M.S.L., W.A.S., D.S., C.R.) and Department of Thoracic Surgery, University of Texas Southwestern Medical School (S.R.L), Dallas, Tex.
  • Daniel Stromberg
    From the Department of Pediatrics (M.S.L., W.A.S., D.S., C.R.) and Department of Thoracic Surgery, University of Texas Southwestern Medical School (S.R.L), Dallas, Tex.
  • Claudio Ramaciotti
    From the Department of Pediatrics (M.S.L., W.A.S., D.S., C.R.) and Department of Thoracic Surgery, University of Texas Southwestern Medical School (S.R.L), Dallas, Tex.

書誌事項

タイトル別名
  • A Prospective, Randomized Study

説明

<jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Background</jats:italic> — </jats:bold> </jats:italic> </jats:bold> The Fontan procedure is the definitive operation for palliation of complex congenital heart disease with single-ventricle physiology. Fenestration of the Fontan circuit allows for shunting of deoxygenated blood to the systemic circulation. This procedure improved the clinical outcomes of patients who are at high risk for poor Fontan results. However, it is controversial whether fenestration is beneficial for standard-risk patients. </jats:p> <jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Methods and Results</jats:italic> — </jats:bold> </jats:italic> </jats:bold> This prospective, randomized trial evaluated the clinical utility of fenestration in patients with standard preoperative risk profiles for Fontan surgery. Forty-nine consecutive patients were assigned to undergo either a fenestrated (25 patients) or nonfenestrated (24 patients) Fontan procedure. The fenestrated and nonfenestrated groups were comparable with respect to age ( <jats:italic>P</jats:italic> =0.944), body surface area ( <jats:italic>P</jats:italic> =0.250), number of preoperative risk factors for poor outcome ( <jats:italic>P</jats:italic> =0.681), cardiopulmonary bypass time ( <jats:italic>P</jats:italic> =0.302), number of patients who required aortic cross-clamping ( <jats:italic>P</jats:italic> =0.240), preoperative oxygen saturation ( <jats:italic>P</jats:italic> =0.101), and number of patients with dominant left ventricular morphology ( <jats:italic>P</jats:italic> =0.534). Patients in the fenestrated group had 55% less total chest tube drainage ( <jats:italic>P</jats:italic> =0.036), 41% shorter total hospitalization ( <jats:italic>P</jats:italic> =0.018), and 67% fewer additional procedures in the postoperative period ( <jats:italic>P</jats:italic> =0.006) than those in the nonfenestrated group. </jats:p> <jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Conclusions</jats:italic> — </jats:bold> </jats:italic> </jats:bold> Baffle fenestration performed at the time of Fontan surgery improves short-term outcome in standard-risk patients by decreasing pleural drainage, hospital length of stay, and need for additional postoperative procedures. </jats:p>

収録刊行物

  • Circulation

    Circulation 105 (2), 207-212, 2002-01-15

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ